Literature DB >> 30604454

Improving inverse docking target identification with Z-score selection.

Stephanie S Kim1, Melanie L Aprahamian1, Steffen Lindert1.   

Abstract

The utilization of inverse docking methods for target identification has been driven by an increasing demand for efficient tools for detecting potential drug side-effects. Despite impressive achievements in the field of inverse docking, identifying true positives from a pool of potential targets still remains challenging. Notably, most of the developed techniques have low accuracies, limit the pool of possible targets that can be investigated or are not easy to use for non-experts due to a lack of available scripts or webserver. Guided by our finding that the absolute docking score was a poor indication of a ligand's protein target, we developed a novel "combined Z-score" method that used a weighted fraction of ligand and receptor-based Z-scores to identify the most likely binding target of a ligand. With our combined Z-score method, an additional 14%, 3.6%, and 6.3% of all ligand-protein pairs of the Astex, DUD, and DUD-E databases, respectively, were correctly predicted compared to a docking score-based selection. The combined Z-score had the highest area under the curve in a ROC curve analysis of all three datasets and the enrichment factor for the top 1% predictions using the combined Z-score analysis was the highest for the Astex and DUD-E datasets. Additionally, we developed a user-friendly python script (compatible with both Python2 and Python3) that enables users to employ the combined Z-score analysis for target identification using a user-defined list of ligands and targets. We are providing this python script and a user tutorial as part of the supplemental information.
© 2019 John Wiley & Sons A/S.

Entities:  

Keywords:  Z-score; inverse docking; molecular docking; virtual screening

Mesh:

Substances:

Year:  2019        PMID: 30604454      PMCID: PMC6606408          DOI: 10.1111/cbdd.13453

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  51 in total

1.  Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking.

Authors:  B Kramer; M Rarey; T Lengauer
Journal:  Proteins       Date:  1999-11-01

2.  Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule.

Authors:  Y Z Chen; D G Zhi
Journal:  Proteins       Date:  2001-05-01

3.  Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.

Authors:  Y Z Chen; C Y Ung
Journal:  J Mol Graph Model       Date:  2001       Impact factor: 2.518

4.  The Protein Data Bank.

Authors:  Helen M Berman; Tammy Battistuz; T N Bhat; Wolfgang F Bluhm; Philip E Bourne; Kyle Burkhardt; Zukang Feng; Gary L Gilliland; Lisa Iype; Shri Jain; Phoebe Fagan; Jessica Marvin; David Padilla; Veerasamy Ravichandran; Bohdan Schneider; Narmada Thanki; Helge Weissig; John D Westbrook; Christine Zardecki
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-05-29

Review 5.  Drug Adverse Reaction Target Database (DART) : proteins related to adverse drug reactions.

Authors:  Zhi Liang Ji; Lian Yi Han; Chun Wei Yap; Li Zhi Sun; Xin Chen; Yu Zong Chen
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Improved protein-ligand docking using GOLD.

Authors:  Marcel L Verdonk; Jason C Cole; Michael J Hartshorn; Christopher W Murray; Richard D Taylor
Journal:  Proteins       Date:  2003-09-01

7.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

8.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

Review 9.  Docking and scoring in virtual screening for drug discovery: methods and applications.

Authors:  Douglas B Kitchen; Hélène Decornez; John R Furr; Jürgen Bajorath
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

10.  Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.

Authors:  Magda N Kosmopoulou; Demetres D Leonidas; Evangelia D Chrysina; Nicolas Bischler; Gerhard Eisenbrand; Constantinos E Sakarellos; Richard Pauptit; Nikos G Oikonomakos
Journal:  Eur J Biochem       Date:  2004-06
View more
  4 in total

1.  Identification of Novel Cyclin A2 Binding Site and Nanomolar Inhibitors of Cyclin A2-CDK2 Complex.

Authors:  Stephanie S Kim; Michele J Alves; Patrick Gygli; Jose Otero; Steffen Lindert
Journal:  Curr Comput Aided Drug Des       Date:  2021       Impact factor: 1.606

2.  Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking.

Authors:  Sergio R Ribone; S Alexis Paz; Cameron F Abrams; Marcos A Villarreal
Journal:  J Comput Aided Mol Des       Date:  2021-11-26       Impact factor: 4.179

3.  Identification of Four Metabolic Subtypes of Glioma Based on Glycolysis-Cholesterol Synthesis Genes.

Authors:  Jinsen Zhang; Xing Xiao; Qinglong Guo; Zixuan Wei; Wei Hua
Journal:  Comput Math Methods Med       Date:  2022-02-21       Impact factor: 2.238

4.  Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.

Authors:  Zhou Zhu; Jian Qin; Chencheng Dong; Jin Yang; Maughan Yang; Jana Tian; Xiaogang Zhong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.